Related Experiment Video
Updated: Feb 2, 2026

Studying the Stoichiometry of Epidermal Growth Factor Receptor in Intact Cells using Correlative Microscopy
Published on: September 11, 2015
SMAD4 Mutation in Small Cell Transformation of Epidermal Growth Factor Receptor Mutated Lung Adenocarcinoma
Nicky D'Haene1, Marie Le Mercier2, Isabelle Salmon2
1Department of Pathology, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium nicky.d.haene@erasme.ulb.ac.be.
Abstract:
The large screening of exons 18 to 21 of the epidermal growth factor receptor (EGFR) gene may lead to the discovery of rare, atypical molecular alterations for which the sensitivity to tyrosine kinase inhibitors (TKIs) remains uncertain. We are reporting a rare exon 18 EGFR mutation (p.E709_710 > D) that confers sensitivity to second-generation EGFR TKI (afatinib), lasting for 1 year. Tumor progression biopsy showed small cell lung cancer transformation, associated with a SMAD4 mutation. KEY POINTS: A rare exon 18 epidermal growth factor receptor mutation with sensitivity to afatinib is reported.Small cell transformation was observed at tumor progression.Acquisition of a SMAD4 mutation was observed at tumor progression.
Insights
A rare epidermal growth factor receptor (EGFR) exon 18 mutation showed sensitivity to afatinib. Tumor progression revealed small cell lung cancer transformation and a SMAD4 mutation.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Screening of epidermal growth factor receptor (EGFR) exons 18-21 can identify rare mutations.
- The clinical significance and treatment sensitivity of these atypical alterations are often uncertain.
Observation:
- A rare exon 18 EGFR mutation (p.E709_710 > D) was identified.
- This mutation conferred sensitivity to the second-generation EGFR tyrosine kinase inhibitor (TKI) afatinib, lasting for one year.
Findings:
- Tumor progression biopsy revealed a transformation to small cell lung cancer.
- A SMAD4 mutation was acquired concurrently with the small cell transformation.
Implications:
- This case highlights a rare EGFR mutation responsive to afatinib.
- It also demonstrates a potential mechanism of acquired resistance involving tumor transformation and SMAD4 mutation in EGFR-mutated lung cancer.
Related Concept Videos
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Viral Mutations
Mutation, Gene Flow, and Genetic Drift
Mutations in Microorganisms
Point and Frameshift Mutations

